diphenyleneiodonium has been researched along with cyclin d1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, LB; Hershenson, MB; Hodge, JA; Li, J; Liu, PT; Page, K; Pestell, RG; Rosner, MR; Vanden Hoek, TL | 1 |
| Kim, CD; Kim, JM; Kim, KH; Kim, KM; Park, YC; Song, JD; Yoo, YH | 1 |
| Chae, IG; Chun, KS; Kim, DH; Lee, S; Park, G; Park, JE | 1 |
3 other study(ies) available for diphenyleneiodonium and cyclin d1
| Article | Year |
|---|---|
Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cattle; Cells, Cultured; Cyclin D1; Gene Expression Regulation; Genes, Reporter; GTP Phosphohydrolases; GTP-Binding Proteins; Luciferases; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth; NADPH Oxidases; Onium Compounds; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; rac GTP-Binding Proteins; Recombinant Fusion Proteins; Signal Transduction; Trachea; Transcription, Genetic | 1999 |
Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
Topics: Cell Cycle; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; HL-60 Cells; Humans; NADPH Oxidases; Neoplasms; Onium Compounds; RNA Interference; RNA, Small Interfering; Signal Transduction; Time Factors; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2008 |
Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcones; Cyclin D1; Cyclin D2; Down-Regulation; Humans; Janus Kinase 2; Kidney Neoplasms; NADPH Oxidases; Onium Compounds; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-mdm2; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Tumor Suppressor Protein p53 | 2017 |